Shaker Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,475
Closed -$246K 99
2025
Q1
$246K Sell
8,475
-10,045
-54% -$321K 0.12% 87
2024
Q4
$688K Sell
18,520
-16
-0.1% -$732 0.29% 66
2024
Q3
$900K Sell
18,536
-9
-0% -$395 0.37% 69
2024
Q2
$742K Sell
18,545
-30,645
-62% -$1.27M 0.32% 72
2024
Q1
$2.16M Buy
49,190
+112
+0.2% +$5.78K 0.91% 44
2023
Q4
$3.04M Buy
49,078
+28,283
+136% +$1.49M 1.42% 26
2023
Q3
$956K Sell
20,795
-157
-0.7% -$8.56K 0.53% 57
2023
Q2
$1.2M Sell
20,952
-61,301
-75% -$2.72M 0.61% 55
2023
Q1
$3.08M Buy
82,253
+966
+1% +$31.7K 1.72% 17
2022
Q4
$2.28M Buy
81,287
+888
+1% +$25.8K 1.41% 24
2022
Q3
$2.26M Buy
80,399
+43,282
+117% +$1.41M 1.51% 24
2022
Q2
$1.29M Buy
37,117
+3,323
+10% +$119K 0.82% 39
2022
Q1
$1.21M Buy
+33,794
New +$958K 0.62% 47

Other funds holding AMPH

Shaker Investments's AMPH Position: Q2 2025 in Review

Shaker Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 8,475 shares — an estimated $246K sold.

Shaker Investments first reported a position in AMPH in Q1 2022 and held it in 13 quarters. The position peaked at $3.08M in Q1 2023. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • Shaker Investments reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Shaker Investments sold 8,475 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $246K.
  • Shaker Investments first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 13 quarters.
  • Shaker Investments's Amphastar Pharmaceuticals position peaked at $3.08M in Q1 2023.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on Shaker Investments's 13F filing for Q2 2025, filed 31 Jul 2025.